As of 2025-07-06, the Relative Valuation of Acerus Pharmaceuticals Corporation (ASP.TO) is 0.50 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 CAD, the upside of Acerus Pharmaceuticals Corporation based on Relative Valuation is 37.7%.
The range of the Relative Valuation is 0.50 - 0.50 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -0.1x - -0.1x | -0.1x |
| Fair Price | 0.50 - 0.50 | 0.50 |
| Upside | 37.7% - 37.7% | 37.7% |
| Date | P/E |